Successful treatment of refractory T-cell acute lymphoblastic leukemia by unmanipulated stem cell transplantation from an HLA 3-loci mismatched (haploidentical) sibling

Bone Marrow Transplantation

Volumn 31, Issue 6, 2003, Pages 507-510

  Ikegame, K ^a   Tanji, Y ^a   Kitai, N ^a   Tamaki, H ^a   Kawakami, M ^a   Fujioka, T ^a   Oka, Y ^a   Maruya, E ^b   Saji, H ^b   Sugiyama, H ^c   Ogawa, H ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Japanese Red Cross Kanto Koshinetsu Block Blood Center   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

ALL; FK506; GVHD; HLA mismatched BMT; Methylprednisolone; Mycophenolate mofetil

Indexed keywords

ANTIBIOTIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; FLUDARABINE; FOSCARNET; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; HLA ANTIGEN; IDARUBICIN; MERCAPTOPURINE; METHOTREXATE; METHYLPREDNISOLONE; MITOXANTRONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TACROLIMUS; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BACTERIAL INFECTION; CANCER REGRESSION; CASE REPORT; CYTOMEGALOVIRUS; DISEASE SEVERITY; DONOR; EPSTEIN BARR VIRUS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; GRAFT VERSUS HOST REACTION; HERPES SIMPLEX VIRUS; HLA MATCHING; HUMAN; LEUKOCYTE COUNT; MALE; MEDICAL DECISION MAKING; MYCOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROPHYLAXIS; SIBLING; STEM CELL TRANSPLANTATION; T CELL LEUKEMIA; THROMBOCYTE COUNT; TREATMENT OUTCOME; VARIABLE NUMBER OF TANDEM REPEAT; VIRUS INFECTION; WHOLE BODY RADIATION;

ADULT; GRAFT VS HOST DISEASE; HAPLOIDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, T-CELL; MALE; SIBLINGS; TISSUE DONORS;

EID: 0037366816     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703858     Document Type: Article

References (9)

1. Henslee-Downey PJ, Abhyankar SH, Parrish RS et al. Use of partially mismatched related donors extends access to allogeneic marrow transplant. Blood 1997; 89: 3864-3872.
2. Aversa F, Tabilio F, Velardi A et al. Treatment of high-risk acute leukemia with T-cell-depleted cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 1998; 339: 1186-1193.
3. Marmont A, Horowitz M, Gale R et al. T-cell depletion of HLA-identical transplants in leukemia. Blood 1991; 78: 2120-2130.
4. Ogawa H, Soma T, Hosen N et al. The combination of tacrolimus, methotrexate, and methylprednisolone completely prevents acute graft-versus-host disease (GVHD) but not chronic GVHD in unrelated bone marrow transplantation. Transplantation 2002; 74: 236-243.
5. Ogawa H, Tsuboi A, Oji Y et al. Successful donor leukocyte transfusion at molecular relapse for a patient with acute myeloid leukemia who was treated with allogeneic bone marrow transplantation: importance of the monitoring of minimal residual disease by WT1 assay. Bone Marrow Transplant 1998; 21: 525-527.
6. Anasetti C, Amos D, Beatty PG et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 1989; 320: 197-204.
7. Aversa F, Tabilio A, Terenzi A et al. Successful engraftment of T-cell-depleted haploidentical 'three-loci' incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994; 84: 3948-3955.
8. Croop JM, Cooper R, Seshadri R et al. Large-scale mobilization and isolation of CD34+ cells from normal donors. Bone Marrow Transplant 2000; 26: 1271-1279.
9. Burlingham W, Railer A, Heisey D et al. The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplantation sibling donors. N Engl J Med 1998; 339: 1657-1664.